We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Organogenesis Holdings
ORGO
$328M
| $327K | 0.06% |
98,602
-196,498
| -67% | -$581K |
|
|
FISV
652
Fiserv Inc
FISV
$27.9B
| $327K | 0.06% |
+2,593
| New | +$305K |
|
653
Western Digital
WDC
$172B
| $327K | 0.06% |
+11,394
| New | +$317K |
|
654
Bio-Rad Laboratories Class A
BIO
$8.47B
| $326K | 0.06% |
860
-391
| -31% | -$159K |
|
655
Cognyte Software
CGNT
$642M
| $326K | 0.06% |
+53,480
| New | +$249K |
|
656
Sinclair Inc
SBGI
$974M
| $326K | 0.06% |
23,554
-11,776
| -33% | -$194K |
|
657
Dynatrace
DT
$12.7B
| $325K | 0.06% |
+6,311
| New | +$296K |
|
658
Sea Limited
SE
$63.9B
| $324K | 0.06% |
+5,589
| New | +$399K |
|
659
Arvinas
ARVN
$530M
| $324K | 0.06% |
13,062
-6,861
| -34% | -$176K |
|
|
RYZ
660
Ryerson Holding Corp
RYZ
$1.59B
| $324K | 0.06% |
7,468
+658
| +10% | +$24.4K |
|
661
TaskUs
TASK
$531M
| $324K | 0.06% |
28,599
+18,448
| +182% | +$224K |
|
662
Pembina Pipeline
PBA
$29B
| $324K | 0.06% |
+10,294
| New | +$329K |
|
663
Black Hills Corp
BKH
$5.68B
| $323K | 0.06% |
5,368
-6,558
| -55% | -$416K |
|
664
Genesco
GCO
$416M
| $323K | 0.06% |
12,889
+6,387
| +98% | +$185K |
|
665
Cheesecake Factory
CAKE
$4.32B
| $323K | 0.06% |
9,328
+3,550
| +61% | +$118K |
|
666
DXP Enterprises
DXPE
$2.57B
| $322K | 0.06% |
+8,855
| New | +$267K |
|
|
CUK
667
DELISTED
Carnival PLC
CUK
| $322K | 0.06% |
+19,012
| New | +$200K |
|
668
Lakeland Financial Corp
LKFN
$1.58B
| $322K | 0.06% |
6,639
+428
| +7% | +$22.4K |
|
669
Pacira BioSciences
PCRX
$1.04B
| $322K | 0.06% |
+8,031
| New | +$332K |
|
|
SAGE
670
DELISTED
Sage Therapeutics
SAGE
| $321K | 0.06% |
6,835
+1,847
| +37% | +$91.9K |
|
|
SUNW
671
DELISTED
Sunworks, Inc.
SUNW
| $321K | 0.06% |
283,650
+131,727
| +87% | +$147K |
|
|
GOOS
672
Canada Goose Holdings
GOOS
$891M
| $320K | 0.06% |
+17,992
| New | +$323K |
|
673
Enterprise Financial Services Corp
EFSC
$2.4B
| $320K | 0.06% |
+8,189
| New | +$339K |
|
674
Fox Factory Holding Corp
FOXF
$779M
| $320K | 0.06% |
2,949
+975
| +49% | +$99.7K |
|
675
Xencor
XNCR
$1.47B
| $320K | 0.06% |
+12,800
| New | +$348K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.